Sapiens’ Upside‑Heavy Asymmetry Amid a Bull‑High‑Vol Cycle

Why the software firm’s strong alpha may outpace its deep drawdown legacy over the next year

SPNS Sapiens International Corporation N.V.

In this report

01

Returns Overview

Period returns, alpha, cumulative performance, distributions

P. 2-3

→

02

Volatility Analysis

Annualized volatility, downside deviation, drawdowns

P. 4-5

→

03

Beta & Correlation

Trailing, upside, downside beta, systematic risk

P. 6-7

→

04

Risk-Adjusted Returns

Sharpe, Sortino, Calmar, Information, Treynor

P. 8-9

→

05

Market Regime Analysis

Bull/bear behavior, capture ratios

P. 10-11

→

06

Investment Highlights & Risk Summary

Executive summary, risk flags, rankings

P. 12-13

→

Returns Overview

Sapiens International Corporation N.V. (SPNS) — Return Performance

Sapiens International Corporation (SPNS) delivered a mixed return profile across the examined horizons. Over the past month the stock posted a modest 0.42% gain, lagging its sector ETF by 3.01%, while over three months it added 1.05% versus a -12.05% sector underperformance. The most pronounced upside occurred in the six‑month window with a 48.55% return, outpacing the sector by 40.68%, and this momentum extended to one year (65.97% vs +46.97%). Longer‑term performance remained strong, with a three‑year total return of 150.43% (alpha +84.52%) but fell short of the sector over five years, delivering 57.54% versus a -14.27% relative lag.

Period Returns vs S&P 500 & XLK

Monthly Returns Heatmap

SPNS

The stock generated significant positive alpha in medium‑term horizons (6M to 3Y), indicating that recent earnings growth and product expansion have resonated with investors beyond sector trends. However, short‑term returns (1M, 3M) were flat or slightly negative relative to the sector, suggesting a period of consolidation after earlier gains. Over the five‑year horizon the company underperformed its sector, reflecting slower compounding compared to peers and highlighting potential valuation concerns for long‑run investors.

Returns Overview

Sapiens International Corporation N.V. (SPNS) — Return Charts

Volatility Analysis

Sapiens International Corporation N.V. (SPNS) — Volatility Profile

Sapiens International Corporation N.V. (SPNS) exhibits markedly higher volatility than the broader market, with an annualized volatility of 38.13% versus the S&P 500's 17.78%, indicating more than double the price fluctuation over a year. The stock’s downside risk is pronounced: a downside deviation of 26.99% and a max drawdown of -53.07% from its November 2021 peak to the November 2022 trough reflect deep, sustained losses that took roughly 18 months to recover, underscoring vulnerability during market stress. While short‑term (60‑day) volatility at 1.83% is modest relative to the long‑term 252‑day figure of 50.45%, the latter remains well above the historical average, suggesting elevated risk persists over longer horizons.

Volatility Metrics

SPNS

The stock’s annualized volatility of 38.13% is more than twice that of the S&P 500, signaling a higher sensitivity to market movements and greater potential for rapid price swings. Downside metrics reinforce this risk profile: a downside deviation of 26.99% translates to larger losses on negative days compared with the benchmark, while the -53.07% max drawdown illustrates the depth of past declines and a recovery period extending over 1.5 years. The current 60‑day volatility of 1.83% sits below the long‑term 252‑day average of 50.45%, indicating a temporary easing in short‑run price swings, yet the elevated annualized figure suggests that investors should remain cautious about sustained volatility.

SPNS’s annualized volatility (38.13%) is more than double the S&P 500 benchmark (17.78%).
Downside deviation of 26.99% signals larger losses on down days relative to market averages.
The max drawdown of -53.07% lasted roughly 18 months, highlighting significant downside exposure.
Short‑term volatility (60‑day) is low at 1.83%, but long‑term volatility remains high at 50.45%.

Positive Characteristics
Recent short‑term volatility has tapered, suggesting a temporary stabilization in price movements.
The stock has fully recovered from its previous drawdown as of July 2024, demonstrating resilience after a deep correction.

Volatility Analysis

Sapiens International Corporation N.V. (SPNS) — Volatility & Drawdown Charts

Beta & Correlation

Sapiens International Corporation N.V. (SPNS) — Beta Profile

Sapiens International Corporation (SPNS) exhibits a trailing beta of 0.977 versus the S&P 500, placing it squarely in the market‑like range (0.8‑1.2). This indicates that, on average, the stock moves roughly in tandem with broad equity markets, neither markedly defensive nor aggressive. However, the upside beta of 0.987 and downside beta of 1.033 reveal a modest asymmetry: the share tends to fall slightly more sharply than it rises during market downturns, a nuance important for risk‑averse investors. The overall R-squared of 21.1% signals that only about one‑fifth of SPNS’s price variance is explained by market movements, leaving roughly 79% driven by idiosyncratic factors, which underscores the potential for diversification benefits despite its market‑like beta.

Beta & Correlation Metrics

SPNS

The trailing beta of 0.977 suggests SPNS behaves similarly to the S&P 500, offering exposure comparable to a broad equity index without the heightened volatility of aggressive stocks. The downside beta exceeding 1 (1.033) implies that in bearish market phases the stock is slightly more sensitive than its upside counterpart, highlighting an asymmetric risk profile that could amplify losses during corrections. With a sector beta of 0.706 versus XLK and a sector correlation of 0.44, the company derives less than half of its movement from technology‑sector dynamics, indicating that much of its risk stems from firm‑specific drivers rather than sector trends.

Trailing beta (0.977) places SPNS in a market‑like risk bucket, aligning its performance closely with the S&P 500.
Downside beta (1.033) exceeds upside beta (0.987), revealing modestly higher sensitivity to market declines.
R-squared of 21.1% means only one‑fifth of price variation is systematic; the majority is idiosyncratic, offering diversification potential.
Systematic risk accounts for 21.1% of total variance while idiosyncratic risk dominates at 78.9%, emphasizing firm‑specific factors.
Sector beta (0.706) is lower than market beta, indicating that sector exposure contributes less to overall volatility than broader market movements.

Positive Characteristics
Market‑like beta provides investors with familiar equity exposure without the heightened risk of aggressive stocks.
Low sector beta (0.706) reduces reliance on technology‑sector performance, offering a buffer if the sector underperforms.
High idiosyncratic component suggests opportunities for active management to capture stock‑specific upside.

Beta & Correlation

Sapiens International Corporation N.V. (SPNS) — Rolling Beta

Positive Notes

Market‑like beta provides investors with familiar equity exposure without the heightened risk of aggressive stocks.

Low sector beta (0.706) reduces reliance on technology‑sector performance, offering a buffer if the sector underperforms.

High idiosyncratic component suggests opportunities for active management to capture stock‑specific upside.

Risk-Adjusted Returns

Sapiens International Corporation N.V. (SPNS) — Risk-Adjusted Performance

Sapiens International Corporation N.V. (SPNS) delivers a modest risk-adjusted return profile, with a Sharpe ratio of 0.564 indicating that the stock generates excess returns above the risk‑free rate but at a level below the benchmark threshold of 1.0 for strong performance. The Sortino ratio of 0.797 exceeds the Sharpe, suggesting that downside volatility is relatively restrained and the company’s return distribution is skewed toward upside gains. While the Calmar ratio of 0.474 points to moderate sensitivity to drawdowns, the Information ratio of 0.372 reflects a modest but consistent ability to generate alpha relative to its benchmark.

Risk-free rate: 3.63% (Fed Funds Rate)

Risk-Adjusted Metrics

SPNS

Ranking SPNS as the sole entity places it at the top of this single‑company analysis for risk-adjusted performance, albeit with room for improvement across most metrics. The Sharpe ratio below 1.0 signals that investors are compensated for risk at a lower rate than typical market leaders, whereas the higher Sortino ratio highlights a favorable downside risk profile. The Calmar ratio suggests that past drawdowns have eroded returns more than desired, and the Information ratio underlines that active management is delivering alpha, but not at the level (>0.5) associated with robust consistency.

Sharpe ratio of 0.564 indicates modest excess return per unit of total risk.
Sortino ratio (0.797) exceeds Sharpe, implying limited downside volatility.
Calmar ratio of 0.474 reveals sensitivity to maximum drawdown, indicating moderate drawdown severity.
Information ratio of 0.372 shows consistent but sub‑threshold alpha generation.
Treynor ratio of 22.011 reflects high return relative to systematic risk, though it must be interpreted alongside beta information.

Positive Characteristics
Sortino ratio surpasses Sharpe, indicating a favorable downside risk profile.
High Treynor ratio suggests strong compensation for market exposure.
Information ratio is positive, demonstrating the ability to generate consistent alpha.

Risk-Adjusted Returns

Sapiens International Corporation N.V. (SPNS) — Rolling Sharpe & Sortino

Positive Notes

Sortino ratio surpasses Sharpe, indicating a favorable downside risk profile.

High Treynor ratio suggests strong compensation for market exposure.

Information ratio is positive, demonstrating the ability to generate consistent alpha.

Market Regime Analysis

Sapiens International Corporation N.V. (SPNS) — Regime Behavior

Sapiens International Corporation N.V. (SPNS) exhibits markedly divergent performance across market regimes, reflecting its sensitivity to both trend direction and volatility. In bull markets with low volatility the stock delivers robust returns of 3.78% per month on average, while in a volatile up‑trend (the current regime) its average monthly gain drops sharply to just 0.57%, indicating reduced upside participation when market swings intensify. Conversely, during bear phases the company shows resilience: in orderly declines it posts an impressive 6.21% average monthly return, but under volatile downturns the stock modestly contracts at -0.33% per month, suggesting a defensive tilt that cushions losses when markets are stressed.

Current Market Regime: Bull-HighVol

Bull-LowVol = calm uptrend • Bull-HighVol = volatile uptrend • Bear-LowVol = orderly decline • Bear-HighVol = crisis

Regime Returns & Capture Ratios

SPNS

Across the four defined regimes SPNS generates strong upside in calm bullish environments (3.78% monthly) but its performance deteriorates markedly when volatility rises, yielding only 0.57% per month in the current Bull‑HighVol setting. In bear markets the stock shines during low‑volatility declines with a 6.21% average gain, effectively acting as a defensive play, yet it experiences slight negative returns (-0.33%) when both direction and volatility are adverse. The upside capture of 133.6% versus a downside capture of 70.8% translates to a capture ratio of 1.89, meaning the stock captures nearly twice as much upside as downside relative to the S&P 500, a favorable risk‑adjusted profile.

Market Regime Analysis

Sapiens International Corporation N.V. (SPNS) — Regime & Capture Charts

Regime Timeline

The company’s upside capture (133.6%) exceeds its downside capture (70.8%), delivering a capture ratio of 1.89, which signals strong asymmetric returns.
Performance in Bull‑HighVol regimes is muted at 0.57% per month, highlighting sensitivity to heightened market turbulence.
In Bear‑LowVol conditions SPNS outperforms with a 6.21% average monthly gain, indicating defensive characteristics during orderly declines.
During Bear‑HighVol periods the stock only loses -0.33% per month, limiting downside risk relative to broader markets.

Positive Characteristics
High upside capture combined with relatively low downside capture provides a favorable risk‑return trade‑off.
Defensive strength in Bear‑LowVol regimes suggests resilience during market corrections without extreme volatility.

Investment Highlights & Risk Summary

Sapiens International Corporation N.V. (SPNS) — Summary & Implications

Sapiens International Corporation N.V. delivered a remarkable 1‑year total return of 65.97%, generating an alpha of 46.97% versus the S&P 500 and outperforming its technology sector ETF (XLK) by 23.18%. The stock’s upside capture of 133.6% combined with a downside capture of only 70.8% indicates that it participates strongly in market rallies while limiting losses during downturns, contributing to its superior relative performance. However, the equity exhibits elevated risk characteristics: annualized volatility of 38.13%, a beta near market (0.977) and a Sharpe ratio of 0.564 suggest modest risk‑adjusted returns, and a historic max drawdown of -53.07% underscores substantial capital loss potential. Investors should weigh the strong return profile against the deep drawdown risk and consider how Sapiens fits within a broader portfolio that can tolerate higher volatility for upside exposure.

Summary Dashboard

Investment Highlights

1‑year total return of 65.97% translates to an absolute gain far exceeding the S&P 500's roughly 19% annual performance, reflecting strong earnings momentum.
Alpha of 46.97% versus the S&P 500 and sector alpha of 23.18% vs XLK demonstrate that the stock has delivered excess returns after accounting for market movements.
Upside capture of 133.6% paired with downside capture of 70.8% yields a capture ratio of 1.88, indicating the company captures nearly double the upside while limiting downside relative to the broader market.
Beta of 0.977 keeps overall market sensitivity neutral, allowing investors to gain exposure without excessive systematic risk.
Downside capture well below 100% suggests resilience in bear markets, providing a defensive tilt within a growth‑oriented technology allocation.

Risk-Return Rankings

SPNS ELEVATED

High return with strong upside capture but marked by extreme volatility and a 53% historical drawdown.

Strength: Exceptional relative alpha (+46.97%) and upside capture (133.6%).

Concern: Deep max drawdown of -53.07% indicating significant capital loss risk.

Key Takeaways

Sapiens outperforms both the broad market and its sector, delivering sizable absolute returns.
Risk‑adjusted metrics are modest; Sharpe (0.564) falls short of the 1.0 benchmark for strong risk efficiency.
The stock’s volatility (38.13%) and historic drawdown highlight a need for risk tolerance.
Upside/downside capture profile offers asymmetric upside potential, useful for growth‑biased portfolios.
Beta near one ensures market correlation without excessive leverage, suitable for diversified tech exposure.

PORTFOLIO IMPLICATIONS

For investors seeking high‑convexity exposure within technology, Sapiens can serve as a satellite holding that adds upside potential while still tracking overall market movements. Its elevated volatility and deep drawdown history suggest it should be weighted modestly—typically no more than 3‑5% of a diversified equity portfolio—to avoid disproportionate risk. Pairing SPNS with lower‑beta, lower‑volatility tech or defensive assets can smooth return streams and mitigate the impact of potential market corrections.

SPNS

Related Reports

Visit finexus.net/reports for more reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.